P04-06. Evolution of an anti-MPER gp41 antibody response that mediates broad HIV-1 cross-neutralization

P04-06. Evolution of an anti-MPER gp41 antibody response that mediates broad HIV-1 cross-neutralization

Bibliographic Details
Main Authors:	Abdool-Karim S, Williamson C, Mlisana K, Madiga M, Abrahams M, Ranchobe N, Moore P, Gray E, Morris L
Format:	Article
Language:	English
Published:	BMC 2009-10-01
Series:	Retrovirology

Similar Items

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
by: Han D, et al.
Published: (2012-09-01)

Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds
by: Oakes, V, et al.
Published: (2018)

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies.
by: Cathrine Scheepers, et al.
Published: (2022-09-01)

Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization.
by: Arthur S Kim, et al.
Published: (2014-07-01)

P09-04. Charge changes in the alpha2-helix in the C3 region of the HIV-1 subtype C envelope mediate neutralization escape
by: Gnanakaran S, et al.
Published: (2009-10-01)

Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.
by: Constantinos Kurt Wibmer, et al.
Published: (2017-01-01)

Adsorption and folding dynamics of MPER of HIV-1 gp41 in the presence of dpc micelle
by: Hartono, Yossa Dwi, et al.
Published: (2013)

A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 determinant for neutralization but not for antigen recognition
by: Weissenhorn W, et al.
Published: (2012-09-01)

The Gp41 Sequence Connecting Mper and Tm Domains Constitutes a Distinct HIV-1 "Fusion Peptide" Targeted by Neutralizing Antibodies
by: Apellaniz, B, et al.
Published: (2014)

Detection of Novel Neutralizing Antibody Reactivities Against The Membrane Proximal External Region (MPER) of gp41 in HIV-1 Infected Humans
by: Shaw George M
Published: (2005-12-01)

Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.
by: Ling Ye, et al.
Published: (2011-01-01)

The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects
by: Huan Liu, et al.
Published: (2018-04-01)

Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA.
by: Shelly J Krebs, et al.
Published: (2014-01-01)

Lipid Binding: A Necessary Evil for Broadly Neutralizing Anti-gp41 Antibodies?
by: Scherer, E, et al.
Published: (2008)

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.
by: Laurent Verkoczy, et al.
Published: (2014-05-01)

Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins
by: Zhang, Si Min, et al.
Published: (2015)

Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins.
by: Si Min Zhang, et al.
Published: (2015-01-01)

Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity
by: Seth H. Pincus, et al.
Published: (2021-07-01)

Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.
by: Penny L Moore, et al.
Published: (2009-09-01)

Correction: Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA.
by: PLOS ONE Staff
Published: (2015-01-01)

Affinity maturation pathway of an anti-MPER neutralizing mAb, CAP206-CH12
by: Tumba NL, et al.
Published: (2012-09-01)

DNA vaccines that express the MPER of HIV-1 gp41 elicit different antibodies depending upon their transmembrane and cytoplasmic domains
by: Scott JK, et al.
Published: (2012-09-01)

P04-39. Recognizing a dynamic HIV-1 target: a structural look at the interaction between bnAb 2F5 and varying gp41 MPER sequences
by: Pai EF, et al.
Published: (2009-10-01)

Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection
by: Karim Salim, et al.
Published: (2008-11-01)

P19-50. Simulation of an MPER peptide samples epitope conformations of two broadly neutralizing antibodies
by: Schmidler SC, et al.
Published: (2009-10-01)

Refined identification of neutralization-resistant CRF02_AG viruses and their sensitivity to anti-MPER neutralizing antibodies
by: Jacob RA, et al.
Published: (2012-09-01)

Deep sequencing reveals an association between HIV-1 subtype C mutations in gp41 MPER epitopes and mother-to-child transmission
by: Yin L, et al.
Published: (2012-09-01)

Neutralizing Antibodies Targeting HIV-1 gp41
by: Christophe Caillat, et al.
Published: (2020-10-01)

Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.
by: Ben-Jiang Ma, et al.
Published: (2011-09-01)

HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies.
by: Ji Wang, et al.
Published: (2011-03-01)

Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity
by: Todd Bradley, et al.
Published: (2016-10-01)

Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.
by: Javier Guenaga, et al.
Published: (2012-01-01)

Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.
by: Lynn Morris, et al.
Published: (2011-01-01)

Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.
by: Guohua Yi, et al.
Published: (2013-01-01)

Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.
by: Catherine A Blish, et al.
Published: (2008-01-01)

P05-13. Fragments of HIV-1 gp41 derivatives presented on virus-like particles with preserved binding affinity for broadly neutralizing antibodies
by: Wagner R, et al.
Published: (2009-10-01)

P19-54 LB. Interrogating the membrane-proximal external region (MPER) of HIV-1 gp140
by: Van Roey G, et al.
Published: (2009-10-01)

Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.
by: Mei-Yun Zhang, et al.
Published: (2012-01-01)

Myomedin scaffold variants targeted to 10E8 HIV-1 broadly neutralizing antibody mimic gp41 epitope and elicit HIV-1 virus-neutralizing sera in mice
by: Milan Kuchař, et al.
Published: (2021-12-01)

Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8.
by: Cinque Soto, et al.
Published: (2016-01-01)